Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Asthma D001249 52 associated lipids
Nerve Degeneration D009410 53 associated lipids
Parkinson Disease D010300 53 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Weight Loss D015431 56 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Reperfusion Injury D015427 65 associated lipids
Neuroblastoma D009447 66 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Melanoma D008545 69 associated lipids
Colitis D003092 69 associated lipids
Coronary Disease D003327 70 associated lipids
Leukemia D007938 74 associated lipids
Stomach Ulcer D013276 75 associated lipids
Alzheimer Disease D000544 76 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Atherosclerosis D050197 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Seizures D012640 87 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Brain Ischemia D002545 89 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Weight Gain D015430 101 associated lipids
Glioma D005910 112 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Edema D004487 152 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Cauwels A et al. Anaphylactic shock depends on PI3K and eNOS-derived NO. 2006 J. Clin. Invest. pmid:16886062
Chiang KP et al. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. 2006 Chem. Biol. pmid:17052608
Coleus forskohlii. Monograph. 2006 Altern Med Rev pmid:16597194
Fernandes CJ and O'Donovan DJ Platelet transfusions in infants with necrotizing enterocolitis. 2006 Curr. Hematol. Rep. pmid:16537050
Wang C et al. Total synthesis of (+/-)-paeonilide. 2006 Org. Lett. pmid:16737293
Louis NA et al. Lipid mediator networks and leukocyte transmigration. 2005 Sep-Oct Prostaglandins Leukot. Essent. Fatty Acids pmid:15979294
Spitzer AL et al. Early nonenhanced abdominal computed tomography can predict mortality in severe acute pancreatitis. 2005 Sep-Oct J. Gastrointest. Surg. pmid:16137586
Akyürek N et al. The effect of platelet activating factor antagonist BN 52021 on bacterial translocation and ICAM-I expression in experimental obstructive jaundice. 2005 Sep-Oct J Invest Surg pmid:16249168
O'Neill C The role of paf in embryo physiology. 2005 May-Jun Hum. Reprod. Update pmid:15790601
Krasheninnikov ME and Pliashkevich IuG [Effects of the platelet activating factor on the proliferation and IgE secretion by U-266BL human myeloma cells]. 2005 Jul-Aug Eksp Klin Farmakol pmid:16193656
Marrache AM et al. Intracellular signaling of lipid mediators via cognate nuclear G protein-coupled receptors. 2005 Jan-Apr Endothelium pmid:16036317
Michibayashi T Platelet aggregation and vasoconstriction related to platelet cyclooxygenase and 12-lipoxygenase pathways. 2005 J. Atheroscler. Thromb. pmid:16020916
Owen JS et al. An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry. 2005 J. Lipid Res. pmid:15520455
Lemieux C et al. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. 2005 Blood pmid:15498854
Bazan HE Cellular and molecular events in corneal wound healing: significance of lipid signalling. 2005 Exp. Eye Res. pmid:15781273
Cuschieri J et al. Calcium/calmodulin-dependent kinase II is required for platelet-activating factor priming. 2005 Shock pmid:15665723
Roudebush WE et al. The significance of platelet-activating factor and fertility in the male primate: a review. 2005 J. Med. Primatol. pmid:15667340
Ottino P et al. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. 2005 Invest. Ophthalmol. Vis. Sci. pmid:15671273
Hidalgo MA et al. Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells. 2005 Br. J. Pharmacol. pmid:15678086
Oku H et al. Inhibitory effects of xanthones from guttiferae plants on PAF-induced hypotension in mice. 2005 Planta Med. pmid:15678383
Lin P et al. Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. 2005 J. Immunol. pmid:15728511
Shimada T et al. Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms. 2005 J. Endocrinol. pmid:15684346
Yasu T et al. Activated leukocytes and endothelial cells enhance retention of ultrasound contrast microspheres containing perfluoropropane in inflamed venules. 2005 Int. J. Cardiol. pmid:15686774
Fell JM Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis. 2005 Early Hum. Dev. pmid:15707723
Schaloske RH et al. Molecular characterization of the lipopolysaccharide/platelet activating factor- and zymosan-induced pathways leading to prostaglandin production in P388D1 macrophages. 2005 Biochim. Biophys. Acta pmid:15708354
Fulkerson PC et al. CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism. 2005 Blood pmid:15802529
Guo NJ et al. [Activation of platelet-neutrophil mediated by platelet-activating factor]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15972139
Souza DG and Teixeira MM The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion. 2005 Mem. Inst. Oswaldo Cruz pmid:15962100
Castro Faria Neto HC et al. Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase. 2005 Mem. Inst. Oswaldo Cruz pmid:15962103
White DC et al. Feasibility of assessment of regulatory lipids in breath condensate as potential presymptomatic harbingers of pulmonary pathobiology. 2005 J. Microbiol. Methods pmid:15963585
Jeon SY et al. Rat model of platelet-activating factor-induced rhinosinusitis. 2005 Ann. Otol. Rhinol. Laryngol. pmid:15966528
Tiemann U et al. Influence of ovarian steroid hormones or platelet-activating factor on mRNA of platelet-activating factor receptor in endometrial explant perfusion cultures from ovariectomized bovine. 2005 Prostaglandins Other Lipid Mediat. pmid:15967160
Lang KS et al. Mechanisms of suicidal erythrocyte death. 2005 Cell. Physiol. Biochem. pmid:15956782
Kita Y et al. A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry. 2005 Anal. Biochem. pmid:15958190
Fang YH et al. [Relationship between serum vWF and PAF in type 2 diabetic patients and diabetic nephropathy]. 2005 Di Yi Jun Yi Da Xue Xue Bao pmid:15958323
Echazarreta AL et al. Lack of systemic oxidative stress during PAF challenge in mild asthma. 2005 Respir Med pmid:15823446
Chen C and Bazan NG Lipid signaling: sleep, synaptic plasticity, and neuroprotection. 2005 Prostaglandins Other Lipid Mediat. pmid:16099392
Vardar S et al. Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats. 2005 J. Periodontol. pmid:15830643
Cheng HH et al. Defect in regulation of Ca2+ movement in platelets from patients with systemic lupus erythematosus. 2005 Pharmacology pmid:15591819
Penna C et al. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15637120
Connelly PW et al. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite. 2005 Free Radic. Biol. Med. pmid:15607900
Tran KC et al. Induction of angiogenesis by platelet-activating factor in the rat striatum. 2005 Neuroreport pmid:16148749
Milias GA et al. Effects of eccentric exercise-induced muscle injury on blood levels of platelet activating factor (PAF) and other inflammatory markers. 2005 Eur. J. Appl. Physiol. pmid:16151835
Hauser CJ et al. Non-specific effects of 4-chloro-m-cresol may cause calcium flux and respiratory burst in human neutrophils. 2005 Biochem. Biophys. Res. Commun. pmid:16168959
Kihara Y et al. Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor. 2005 J. Exp. Med. pmid:16172262
Tian X and Bazan NG Neuroprotection by platelet-activating factor antagonism. 2005 Ann. N. Y. Acad. Sci. pmid:16179552
Nagata M et al. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils. 2005 Int. Arch. Allergy Immunol. pmid:15947477
Tunc SE et al. Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet's patients. 2005 Rheumatol. Int. pmid:15004723
Löhrke B et al. Polar phospholipids from bovine endogenously oxidized low density lipoprotein interfere with follicular thecal function. 2005 J. Mol. Endocrinol. pmid:16326838
Besana A et al. Lipids and two-pore domain K+ channels in excitable cells. 2005 Prostaglandins Other Lipid Mediat. pmid:16099395